The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest
- PMID: 16452181
- DOI: 10.1158/0008-5472.CAN-05-3427
The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest
Abstract
The activity of mammalian SWI/SNF-related chromatin remodeling complexes is crucial for differentiation, development, and tumor suppression. Cell cycle-regulating activities dependent on the complexes include induction of the p21(WAF1/CIP1) kinase inhibitor and repression of E2F-responsive promoters. These responses are linked through effects on pRb phosphorylation, but the direct role of the SWI/SNF-related complexes in their regulation is not fully understood. Results presented here reveal that the complexes are required for regulation of a distinct pathway of proliferation control involving repression of c-myc expression in differentiating cells. This involves direct promoter targeting of the c-myc gene by the complexes. Induction of p21(WAF1/CIP1) is specifically dependent on prior repression of c-myc, but repression of E2F-responsive genes is dissociable from the regulation of c-myc and p21(WAF1/CIP1).
Similar articles
-
The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest.Cancer Res. 2005 Oct 15;65(20):9236-44. doi: 10.1158/0008-5472.CAN-05-1225. Cancer Res. 2005. PMID: 16230384
-
De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.Int J Oncol. 2008 Aug;33(2):375-80. Int J Oncol. 2008. PMID: 18636159
-
DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.Cancer Res. 2006 Jul 1;66(13):6579-88. doi: 10.1158/0008-5472.CAN-05-2415. Cancer Res. 2006. PMID: 16818630
-
When the SWI/SNF complex remodels...the cell cycle.Oncogene. 2001 May 28;20(24):3067-75. doi: 10.1038/sj.onc.1204331. Oncogene. 2001. PMID: 11420722 Review.
-
Lost in transcription: p21 repression, mechanisms, and consequences.Cancer Res. 2005 May 15;65(10):3980-5. doi: 10.1158/0008-5472.CAN-04-3995. Cancer Res. 2005. PMID: 15899785 Review.
Cited by
-
Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries.Int J Mol Sci. 2021 Apr 29;22(9):4750. doi: 10.3390/ijms22094750. Int J Mol Sci. 2021. PMID: 33947138 Free PMC article.
-
Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.Lab Invest. 2010 May;90(5):724-38. doi: 10.1038/labinvest.2010.66. Epub 2010 Mar 8. Lab Invest. 2010. PMID: 20212451 Free PMC article.
-
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.Nat Genet. 2011 Oct 30;43(12):1219-23. doi: 10.1038/ng.982. Nat Genet. 2011. PMID: 22037554
-
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers.Gynecol Oncol Res Pract. 2017 Oct 31;4:17. doi: 10.1186/s40661-017-0052-y. eCollection 2017. Gynecol Oncol Res Pract. 2017. PMID: 29093822 Free PMC article. Review.
-
An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.FEBS Lett. 2010 Aug 4;584(15):3260-8. doi: 10.1016/j.febslet.2010.05.030. Epub 2010 May 21. FEBS Lett. 2010. PMID: 20493850 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
